{"url":"https://lda.senate.gov/api/v1/filings/4d2f42ff-8ae9-45c8-a0ce-e2e97a205482/","filing_uuid":"4d2f42ff-8ae9-45c8-a0ce-e2e97a205482","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4d2f42ff-8ae9-45c8-a0ce-e2e97a205482/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-10T08:26:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.senate.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":211044,"url":"https://lda.senate.gov/api/v1/clients/211044/","client_id":1008822,"name":"NERVGEN PHARMA CORP.","general_description":"Medical, pharma","client_government_entity":false,"client_self_select":null,"state":null,"state_display":null,"country":"CA","country_display":"Canada","ppb_state":null,"ppb_state_display":null,"ppb_country":"CA","ppb_country_display":"Canada","effective_date":"2021-05-12"},"lobbying_activities":[{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Legislation related to spinal cord injury research and treatment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Legislation related to central nervous system research and therapeutics.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":false},{"lobbyist":{"id":139293,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation related to spinal cord injury research, therapeutics and approvals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}